MUMBAI, India, June 26 -- Intellectual Property India has published a patent application (202617067597 A) filed by C Therapeutics, Inc. on May 29, 2026, for Compounds For The Degradation Of Mutant Braf.
Inventors include Jackson, Katrina L.; Liang, Yanke; Hanley, Ronan, Patrick Number; Kreger, Bridget; and Pollock, Roy, Macfarlane.
The application for the patent was published on June 19, 2026, under issue no. 25/2026.
Abstract: The present invention provides compounds or their pharmaceutically acceptable salts and their pharmaceutical compositions that can be administered to a host such as a human in need thereof for the treatment of a disorder, such as cancer, mediated by mutant BRAF. The compounds efficiently degrade Class I, II and III mutant BRAF proteins.
Disclaimer: Curated by HT Syndication.
